# MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

> **NCT07312136** · — · ENROLLING_BY_INVITATION · sponsor: **Linkoeping University** · enrollment: 317 (estimated)

## Conditions studied

- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- Cirrhosis
- Advanced Fibrosis
- Sarcopenia
- Obesity & Overweight
- Type 2 Diabetes
- Hypertension
- OSAS (Obstructive Sleep Apneas Syndrome)
- Metabolic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07312136
- **Lead sponsor:** Linkoeping University
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-16
- **Primary completion:** 2031-12-31
- **Final completion:** 2034-12-31
- **Target enrollment:** 317 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07312136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07312136, "MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07312136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*